Long-term treatment with agomelatine: prevention of relapse in patients with Major Depressive Disorder over 10 months

被引:15
作者
Goodwin, G. M. [1 ]
Rouillon, F. [2 ]
Emsley, R. [3 ]
机构
[1] Univ Oxford, Dept Psychiat, Oxford, England
[2] Hop St Anne, Serv CMME, F-75674 Paris, France
[3] Univ Stellenbosch, Fac Hlth Sci, ZA-7505 Tygerberg, South Africa
关键词
D O I
10.1016/S0924-977X(08)70471-1
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S338 / S339
页数:2
相关论文
共 3 条
[1]
Placebo-controlled trial of agomelatine in the treatment of major depressive disorder [J].
Kennedy, SH ;
Emsley, R .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 (02) :93-100
[2]
Lôo H, 2002, INT CLIN PSYCHOPHARM, V17, P239
[3]
Efficacy of agomelatine, a MT1/MT2 receptor agonist with 5-HT2C antagonistic properties, in major depressive disorder [J].
Olie, Jean Pierre ;
Kasper, Siegfried .
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2007, 10 (05) :661-673